Endo180 Antibodies

Santa Cruz Biotechnology features a diverse variety of Endo180 monoclonal antibodies for advanced research in cell biology and tissue remodeling. Endo180 Antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Endo180, also known as CD280, is a receptor that plays a critical role in the endocytosis of collagen and other extracellular matrix components, influencing cellular processes such as migration, adhesion, and tissue repair. CD280 function is particularly significant in cancer metastasis and fibrosis, making Endo180 an important target for therapeutic interventions. Understanding Endo180's role in cellular processes can provide insights into disease mechanisms and potential treatment strategies. Research has shown that CD280 is expressed in various cell types, including fibroblasts, macrophages, and certain cancer cells. Endo180's ability to regulate collagen turnover makes it particularly relevant in wound healing and tissue regeneration studies. The role of CD280 in cancer progression has sparked interest in developing targeted therapies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of Endo180's role in human health and disease development.